BelgiumNetherlandsSwedenProof of Principle of the best-in-class therapeutic mRNA cancer vaccine
Dates: 01/02/2021 31/07/2025 Topic: Tool Project type: Clinic Theranostic Immunotherapy Project target: Cancer Vaccines Financing: H2020-EU.3.1. – SOCIETAL CHALLENGES – Health; demographic change and well-being H2020-EU.3.1.3. – Treating and managing disease Other Participating agents: ETHERNA IMMUNOTHERAPIES Keywords: vaccine; oncoology; HPV16; RNA; Countries: Belgium; Sweden; Netherlands Project page: Access page